Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  DIRECTORS REPORT
Directors Report      
Mankind Pharma Ltd.
March 2021

Description of state of companies affair

On a consolidated basis, the revenue for FY 2021 was ?6,223.90 crore, higher by 6 percent over the previous year’s revenue of ? 5871.87 crore. The profit after tax (PAT) for FY 2021 and FY 2020 was ?1,293.54 crore and ? 1052.10 crore respectively registering a growth of 22.95 percent over the PAT of FY2020. On a standalone basis, the revenue for FY 2021 was ?5,529.60 crore, higher by 15.33 percent over the previous year’s revenue of ?4794.41 crore in FY 2020. The PAT for FY 2021 was ?1,082.82 crore registering a growth of 13.87 percent over the PAT of ?950.90 crore for FY 2020.

Details regarding energy conservation

Conservation of energy (i) the steps taken or impact on conservation of energy 1. 15 Ozone systems installed in power distribution system to avoid microbial load in the distribution system. 2. Variable Frequency Drive (“VFD”) installed for Effluent Treatment Plant (“ETP”), Heating, Ventilation and Air Conditioning system (“HVAC”), Air Compressor and Air Handling Unit (“AHU”) to save energy. 3. Orifice installed in Total Organic Carbon analyzer to save water usage. 4. Motion sensors installed in washrooms and admin office and light sensors installed in streetlights resulting in power saving. 5. One DG set of 1010 KVA capacity added to optimize the power load. 6. Annunciator System installed to monitor critical and non-critical UPS Power Failure to minimize the down time. 7. Treated water from Effluent Treatment Plant is used in cooling tower and boiler to save water. 8. Reduced daily draining of cooling tower water by introducing new dosing chemical Ecoclean and reusing the same treated water thereby saving water as well as electricity consumption. 9. Re-using of soft water from liquid bottle washing line for cooling tower operation. 10. Condensate water is being collected and used in boiler and for hot water circulation. 11. Temperature sensors installed in cooling towers to save power consumption 12. Rainwater harvesting system installed to reduce groundwater consumption. (ii) the steps taken by the company for utilizing alternate sources of energy New biofuel boiler of 6 Tons per hour (“TPH”) capacity installed resulting in zero hydro carbon generation (iii) the capital investment on energy conservation equipment 1. Installation of ozone systems 2. Variable Frequency Drive installed in ETP, HVAC and AHU 3. Installation of Auto Tube Cleaning System 4. New Diesel Generator installation done for power load optimization and fuel saving.

Details regarding technology absorption

(i) the efforts made towards technology absorption 1. Online particle counter installed on vial line. 2. L2 integration of water distribution using SCADA system to reduce the data loss breakdown. 3. Multi-Column Distillation Plants (“MCDP”) and Pure Steam Generation (“PSG”) room segregation to reduce the heat load of water system in Air handling unit. 4. UPS (40KVAx2 and 20KVAx2) system installed and commissioned for QC requirements.. 5. 60 KVA UPS commissioned for the Hoonga packaging machine. 6. New water system installed in vial-block to fulfill the requirements 7. 16 nos. of Dynamic Pass Box installed and 6 nos. of Dust Collector installed and commissioned for the OSD block. 8. 1 Laminar Air Flow installed in solvent dispensing area 9. 2 Stability Chambers and 1 Walk-in cooling Chamber installed 10. Nitrogen Manifold System installed and distributed to sampling area. 11. 2 BQS and 2 Vectra machine imported from ACG and installed for production capacity enhancement. 12. UF and RO systems installed in ETP to utilize treated water 13. New purified water loop system installed to fulfill the expansion area requirements. (ii) the benefits derived like product improvement, cost reduction, product development or import substitution 1. Inspection camera installed in 2 Kulbindra machines to reduce rejection 2. In-house workshop for repair and maintenance made operational 3. Reduced product rejection due to power tripping of 2 Fette Compression Machine by providing separate UPS power supply 4. In-house modifications made on packing turn-table to resolve bottle falling issue. 5. One new static pass box installed in packing area for scrap out. 6. Upgradation in EMS/BMS system and installed SQL system to avoid the data losses issue. 7. Installation of track and trace system to fulfill the production requirement. (iii) in case of imported technology (imported during the last three years reckoned from the beginning of the financial year) (a) the details of technology imported 1. Granule Blender of Cone air (US technology) 2. 3-piece vial line for ophthalmic products (Imported from Italy). 3. 2 Nos. of Gas Chromatography (GC) systems from Shimandju-Japan & Agilent –Germany. 4. Particle measurement system from Malvern-UK 5. On line Total Organic Carbon analyzer system from GE 6. GF filling machine (Italy). 7. Water system from MilliQ (US) 8. KF/Autotitrator/UV- from-Metler. 9. Online TOC analyser commissioned at water system 10. New Truking line (China). 11. LAST Autoclave from Italy. 12. Head space oxygen analyzer (U.S.) (b) the year of import; 1. 2018 2. 2018 3. 2-Shimadzu -2018, 1-Agilent-2017 and 1-Agilent-2018 4. 2018 5. 2018 6. 2018 7. 2019 8. 2020 9. 2020 10. 2020 11. 2020 12. 2021 (c) whether the technology been fully absorbed Yes (d) if not fully absorbed, areas where absorption has not taken place, and the reasons thereof NA

Details regarding foreign exchange earnings and outgo

During the year, foreign exchange earning was ?192.42 Crore and foreign exchange outgo was ?65.28 Crore.

Disclosures in director’s responsibility statement

Pursuant to the requirement clause (c) of sub-section (3) of Section 134 of the Companies Act, 2013, your Directors confirm that: (a) in the preparation of the annual accounts, the applicable accounting standards had been followed along with proper explanation relating to material departures; (b) the directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit and loss of the Company for that period; (c) the directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities; (d) the directors had prepared the annual accounts on a going concern basis; and (e) the directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.

Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.